top of page
Science Lab_edited.png

Bioequivalence and Phase One Unit

Central & Eastern Europe Research Institute (CEERI) operates phase I & bioequivalence units with multiple centers strategically located across CEE Region. These state-of-the-art centers are fully equipped to conduct comprehensive BE and early phase studies, adhering to rigorous international standards. CEERI ensures streamlined research processes, providing reliable data and expertise for pharmaceutical and clinical development. Each unit is designed to meet the needs of the industry, offering specialized services and a collaborative approach to ensure consistency and high-quality results across all sites. 

shutterstock_710229949_ed_edited.jpg

Units Highlights

1,200+

Early Phase & Bioequivalence Studies Conducted

20

Years of Research Experience 

20,000+

Patients and Volunteers

Research Qualified Personnel with Strong Academic Backgrounds

Operating across Several Countries in Central & Eastern Europe 

pharmacology and ph1 unit.jpg

The units make use of the following facilities: 

  • Large sections exceeding 1,300 square meters with beds for patients and volunteers 

  • Examination and research subject rooms 

  • Pharmacies/Medication storage rooms 

  • State-of-the-art diagnostic and bioanalytical laboratories 

  • Access to emergency services 

  • Storage and archiving rooms 

The Units offer services for: 

Integrated single and multiple ascending dose studies

Bioequivalence studies

Food-effect studies

Drug-drug interaction studies

Phase 1a studies

Phase 1b studies 

shutterstock_710229949_ed_edited.jpg

Advantages

State-of-the-Art Facilities

Our partnership with big academic centers ensures cutting-edge technology and infrastructure
for high-quality studies

Experienced Investigators

A strong pool of qualified investigators ensures high-quality study execution and adherence to international standards

A large patient and volunteer population allows for swift participant recruitment, expediting study timelines

Rapid Enrollment

Stringent quality control processes ensure data integrity and safety

Quality Assurance

Competitive pricing for clinical trials, combined with a well-trained workforce, offers significant savings without compromising quality

Cost-Effectiveness

Streamlined Processes

Optimized workflows accelerate timelines, ensuring efficient and timely trial execution

bottom of page